Background Globally, populations are ageing, with an associated increase in the global chronic illness burden (The Lancet, Global Health Metrics, 2017). This implies longer illness trajectories and more need for medical decision-making across the illness trajectory and at end of life. In this context, there has been growing interest in advance care planning (ACP). ACP is a voluntary process of reflection and discussion, usually undertaken with the support of a health or care professional, concerning goals and preferences for future care (Rietjens et al., 2017). ACP can be undertaken at any time but is especially relevant for those living with chronic and progressive illness and has been widely recommended as an integral part of chronic and long-term care (The Lancet, Global Health Metrics, 2017; Prince et al., 2016; Hall et al., 2011). ACP discussions are generally documented to inform care in the event of loss of capacity. In the United States (US), for example, advance directives (living wills) are used to set out treatment preferences, broader goals and values and to assign Durable Power of Attorney. In England, advance statements set out general preferences, while advance decisions specify treatment refusals. Lasting Power of Attorney for Health and Welfare can also be assigned. While legal frameworks and terminology differ, similar provisions exist in Canada, Australia, New Zealand and numerous other countries. In research, ACP has been associated with fewer emergency admissions, hospitalizations, burdensome treatments and hospital deaths, as well as reduced hospital costs, greater concordance of treatment with patient preferences and improved carer satisfaction (